ANTI-MALALUARE AGENTS

VE6142020000125SUndetermined Publication Date: 2022-02-17MERCK SHARP & DOHME CORP
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
VE · VE
Patent Type
Designs
Current Assignee / Owner
MERCK SHARP & DOHME CORP
Filing Date
2020-08-17
Publication Date
2022-02-17
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

The present invention provides methods for the treatment of malaria comprising the administration of compounds of formula (I), or a pharmaceutically acceptable salt thereof, to a subject in need, wherein the variables are as defined herein. The invention also provides uses of the compounds of formula (I), as defined herein, for inhibiting the activity of plasmapsin X, plasmapsin IX, or plasmapsin XYIX, for the treatment of Plasmodium infection, and for the treatment of malaria. TREATMENT METHODS ARE ALSO PROVIDED THAT INCLUDE THE ADMINISTRATION OF ONE OR MORE ANTI-MALALUIDEC COMPOUNDS.